| Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review D Shaweno, M Karmakar, KA Alene, R Ragonnet, ACA Clements, ... BMC medicine 16 (1), 193, 2018 | 157 | 2018 |
| Risk of active tuberculosis in the five years following infection... 15%? JM Trauer, N Moyo, EL Tay, K Dale, R Ragonnet, ES McBryde, ... Chest 149 (2), 516-525, 2016 | 145 | 2016 |
| The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains ES McBryde, MT Meehan, TN Doan, R Ragonnet, BJ Marais, V Guernier, ... International Journal of Infectious Diseases 56, 14-20, 2017 | 104 | 2017 |
| High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? R Ragonnet, JM Trauer, JT Denholm, BJ Marais, ES McBryde BMC infectious diseases 17 (1), 36, 2017 | 75 | 2017 |
| Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology JM Caldwell, X Le, L McIntosh, MT Meehan, S Ogunlade, R Ragonnet, ... Paediatric Respiratory Reviews 39, 32-39, 2021 | 54 | 2021 |
| Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study TN Doan, GJ Fox, MT Meehan, N Scott, R Ragonnet, K Viney, JM Trauer, ... Journal of Antimicrobial Chemotherapy 74 (1), 218-227, 2019 | 52 | 2019 |
| Revisiting the natural history of pulmonary tuberculosis: a Bayesian estimation of natural recovery and mortality rates R Ragonnet, JA Flegg, SL Brilleman, EW Tiemersma, YA Melsew, ... Clinical Infectious Diseases 73 (1), e88-e96, 2021 | 51 | 2021 |
| Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study JM Caldwell, E de Lara-Tuprio, TR Teng, MRJE Estuar, RFR Sarmiento, ... The Lancet Regional Health–Western Pacific 14, 2021 | 49 | 2021 |
| Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries R Ragonnet, JM Trauer, N Geard, N Scott, ES McBryde BMC medicine 17 (1), 208, 2019 | 49 | 2019 |
| Understanding how Victoria, Australia gained control of its second COVID-19 wave JM Trauer, MJ Lydeamore, GW Dalton, D Pilcher, MT Meehan, ... Nature Communications 12 (1), 6266, 2021 | 46 | 2021 |
| Optimally capturing latency dynamics in models of tuberculosis transmission R Ragonnet, JM Trauer, N Scott, MT Meehan, JT Denholm, ES McBryde Epidemics 21, 39-47, 2017 | 46 | 2017 |
| Parallel surrogate-assisted optimization: Batched Bayesian Neural Network-assisted GA versus q-EGO G Briffoteaux, M Gobert, R Ragonnet, J Gmys, M Mezmaz, N Melab, ... Swarm and Evolutionary Computation 57, 100717, 2020 | 42 | 2020 |
| Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact R Ragonnet, JM Trauer, ES McBryde, R Houben, JT Denholm, A Handel, ... The international journal of tuberculosis and lung disease 21 (1), 60-66, 2017 | 39 | 2017 |
| Modelling direct and herd protection effects of vaccination against the SARS‐CoV‐2 Delta variant in Australia ES McBryde, MT Meehan, JM Caldwell, AI Adekunle, ST Ogunlade, ... Medical Journal of Australia 215 (9), 427-432, 2021 | 34 | 2021 |
| Ethics of selective restriction of liberty in a pandemic J Cameron, B Williams, R Ragonnet, B Marais, J Trauer, J Savulescu Journal of Medical Ethics 47 (8), 553-562, 2021 | 33 | 2021 |
| Modular programming for tuberculosis control, the “AuTuMN” platform JMC Trauer, R Ragonnet, TN Doan, ES McBryde BMC infectious diseases 17 (1), 546, 2017 | 30 | 2017 |
| Scenario analysis for programmatic tuberculosis control in Western Province, Papua New Guinea JM Trauer, JT Denholm, S Waseem, R Ragonnet, ES McBryde American journal of epidemiology 183 (12), 1138-1148, 2016 | 30 | 2016 |
| Vaccination programs for endemic infections: modelling real versus apparent impacts of vaccine and infection characteristics R Ragonnet, JM Trauer, JT Denholm, NL Geard, M Hellard, ES McBryde Scientific reports 5 (1), 15468, 2015 | 24 | 2015 |
| Sustaining effective COVID-19 control in Malaysia through large-scale vaccination P Jayasundara, KM Peariasamy, KB Law, KNK Abd Rahim, SW Lee, ... Epidemics 37, 100517, 2021 | 23 | 2021 |
| Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands R Ragonnet, BM Williams, A Largen, J Nasa Jr, T Jack, MK Langinlur, ... International Journal of Epidemiology 51 (5), 1433-1445, 2022 | 22 | 2022 |
James TrauerMonash UniversityVerified email at monash.edu
